Category : Search result: pharmaceutical competition


Canada Men's Rugby Enters World Nations Cup 2026

Canadian men's rugby team will compete in the World Rugby Nations Cup starting next year, marking significant international exposure. Learn about this exciting development for Canadian rugby.

J&J buys Halda Therapeutics for $3.05 billion

Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.

Barbados Launches US$200M Life Sciences Hub

Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.

Pfizer wins $10B obesity drug takeover battle

Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.

Border Collies Rule the Arena at Yorkton Harvest Showdown

Witness the breathtaking spectacle of border collies showcasing their incredible herding skills at Saskatchewan's premier agricultural event. These brilliant canine athletes prove why they're the undisputed champions of the arena.

Trump's Plan to Slash Obesity Drug Prices

Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.

Canada's Eurovision Prospects: The Real Story

Explore Canada's complex journey toward potentially competing in Eurovision. From broadcaster requirements to geopolitical challenges, discover what stands between Canadian artists and the iconic European stage.

Trump's Drug Price Plan Backfires, Helps Democrats

Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Page 3 of 4